de Bruijn, Roderick <br/><br/>
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.  [electronic resource] 

 -  European urology oncology  04 2020 
 - 168-173 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2588-9311 
<br/><br/><label>Standard No.: </label>10.1016/j.euo.2019.12.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Renal Cell--drug therapy<br/>Cytoreduction Surgical Procedures--methods<br/>Female<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Nephrectomy--methods<br/>Prospective Studies<br/>Retrospective Studies<br/>Vascular Endothelial Growth Factor A--therapeutic use